Your browser doesn't support javascript.
loading
Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma.
Schieffer, Kathleen M; Feldman, Alexander Z; Kautto, Esko A; McGrath, Sean; Miller, Anthony R; Hernandez-Gonzalez, Maria Elena; LaHaye, Stephanie; Miller, Katherine E; Koboldt, Daniel C; Brennan, Patrick; Kelly, Benjamin; Wetzel, Amy; Agarwal, Vibhuti; Shatara, Margaret; Conley, Suzanne; Rodriguez, Diana P; Abu-Arja, Rolla; Shaikhkhalil, Ala; Snuderl, Matija; Orr, Brent A; Finlay, Jonathan L; Osorio, Diana S; Drapeau, Annie I; Leonard, Jeffrey R; Pierson, Christopher R; White, Peter; Magrini, Vincent; Mardis, Elaine R; Wilson, Richard K; Cottrell, Catherine E; Boué, Daniel R.
Afiliação
  • Schieffer KM; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute At Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH, 43215 , USA. Kathleen.Schieffer@nationwidechildrens.org.
  • Feldman AZ; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL , USA.
  • Kautto EA; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute At Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH, 43215 , USA.
  • McGrath S; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute At Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH, 43215 , USA.
  • Miller AR; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute At Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH, 43215 , USA.
  • Hernandez-Gonzalez ME; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute At Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH, 43215 , USA.
  • LaHaye S; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute At Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH, 43215 , USA.
  • Miller KE; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute At Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH, 43215 , USA.
  • Koboldt DC; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute At Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH, 43215 , USA.
  • Brennan P; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Kelly B; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute At Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH, 43215 , USA.
  • Wetzel A; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute At Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH, 43215 , USA.
  • Agarwal V; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute At Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH, 43215 , USA.
  • Shatara M; Division of Hematology/Oncology, Department of Pediatrics, Nemours Children's Health System, Orlando, FL, USA.
  • Conley S; Division of Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
  • Rodriguez DP; Division of Hematology, Oncology, and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, USA.
  • Abu-Arja R; Department of Radiology, Nationwide Children's Hospital, Columbus, OH, USA.
  • Shaikhkhalil A; Division of Hematology, Oncology, and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, USA.
  • Snuderl M; Division of Gastroenterology & Hepatology & Nutrition, Nationwide Children's Hospital, Columbus, OH, USA.
  • Orr BA; Department of Pathology, New York University Langone Health, New York City, NY, USA.
  • Finlay JL; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Osorio DS; Division of Hematology, Oncology, and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, USA.
  • Drapeau AI; Division of Hematology and Oncology, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Leonard JR; Departments of Pediatrics and Radiation Oncology, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Pierson CR; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA.
  • White P; Division of Hematology, Oncology, and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, USA.
  • Magrini V; Division of Hematology and Oncology, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Mardis ER; Division of Neurosurgery, Nationwide Children's Hospital, Columbus, OH, USA.
  • Wilson RK; Department of Neurosurgery, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Cottrell CE; Division of Neurosurgery, Nationwide Children's Hospital, Columbus, OH, USA.
  • Boué DR; Department of Neurosurgery, The Ohio State University College of Medicine, Columbus, OH, USA.
Acta Neuropathol Commun ; 9(1): 61, 2021 04 07.
Article em En | MEDLINE | ID: mdl-33827698
ABSTRACT
Retinoblastoma is a childhood cancer of the retina involving germline or somatic alterations of the RB Transcriptional Corepressor 1 gene, RB1. Rare cases of sellar-suprasellar region retinoblastoma without evidence of ocular or pineal tumors have been described. A nine-month-old male presented with a sellar-suprasellar region mass. Histopathology showed an embryonal tumor with focal Flexner-Wintersteiner-like rosettes and loss of retinoblastoma protein (RB1) expression by immunohistochemistry. DNA array-based methylation profiling confidently classified the tumor as pineoblastoma group A/intracranial retinoblastoma. The patient was subsequently enrolled on an institutional translational cancer research protocol and underwent comprehensive molecular profiling, including paired tumor/normal exome and genome sequencing and RNA-sequencing of the tumor. Additionally, Pacific Biosciences (PacBio) Single Molecule Real Time (SMRT) sequencing was performed from comparator normal and disease-involved tissue to resolve complex structural variations. RNA-sequencing revealed multiple fusions clustered within 13q14.1-q21.3, including a novel in-frame fusion of RB1-SIAH3 predicted to prematurely truncate the RB1 protein. SMRT sequencing revealed a complex structural rearrangement spanning 13q14.11-q31.3, including two somatic structural variants within intron 17 of RB1. These events corresponded to the RB1-SIAH3 fusion and a novel RB1 rearrangement expected to correlate with the complete absence of RB1 protein expression. Comprehensive molecular analysis, including DNA array-based methylation profiling and sequencing-based methodologies, were critical for classification and understanding the complex mechanism of RB1 inactivation in this diagnostically challenging tumor.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retinoblastoma / Neoplasias Encefálicas / Ubiquitina-Proteína Ligases / Proteínas de Ligação a Retinoblastoma Tipo de estudo: Guideline / Prognostic_studies Limite: Humans / Infant / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retinoblastoma / Neoplasias Encefálicas / Ubiquitina-Proteína Ligases / Proteínas de Ligação a Retinoblastoma Tipo de estudo: Guideline / Prognostic_studies Limite: Humans / Infant / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article